Skip to main content
2019
Publication, report or update

In 2019, Professor Lynne Emmerton led the review of name similarity for:

  • Monoclonal antibodies (MABs) (commonly ending in the suffix ‘mab’)
  • Tyrosine kinase (factor) inhibitors (TKIs) (commonly ending in the suffix ‘nib’).

This included the theoretical risk of confusion within these classes of medicines in clinical practice, including the similarity in clinical indication, with a view to producing a specialised list of medicines. The results of this review can be found in this publication.

2020
Newsletter

This issue includes items on patient safety practices, potentially preventable readmissions, patient and family engagement, transitions of care, homelessness, medication safety, medication reconciliation and Hepatitis C virus and more.

Also covered is the latest issue of Public Health Research & Practice along with the latest online papers from BMJ Quality & Safety and the International Journal for Quality in Health Care and the latest from the UK’s NICE.

2020
Spreadsheet or data set

This file contains rates for those SA3s that fall in the top 10% or bottom 10% of all SA3s for each of the five years for these indicators:

  • Number of PBS/RPBS prescriptions dispensed for antimicrobials per 100,000 people, 2013–14 to 2017–18
  • Number of PBS/RPBS prescriptions dispensed for amoxicillin per 100,000 people, 2013–14 to 2017–18 
  • Number of PBS/RPBS prescriptions dispensed for amoxicillin-clavulanate per 100,000 people, 2013–14 to 2017–18 

 

Back to top